Topical treatment shown to inhibit HIV and herpes simplex virus infection
Mount Sinai School of Medicine researchers demonstrated that a gel applied in the vagina provides protection from both the human immunodeficiency virus (HIV) and the herpes simplex Virus. The study, presented at the 12th Conference on Retroviruses and Opportunistic Infections, is the first to show that a gel can retain anti-viral activity within the human vagina. The study, which was fund...Elusive HIV shape change revealed; Key clue to how virus infects cells
Structural biologists at Children's Hospital Boston and Harvard Medical School have shown how a key part of the human immunodeficiency virus (HIV) changes shape, triggering other changes that allow the AIDS virus to enter and infect cells. Their findings, published in the Feb. 24 issue of the journal Nature, offer clues that will help guide vaccine and treatment approaches. Researchers led...Research advances quest for HIV-1 vaccine
Scientists have uncovered new information that may help guide design of vaccines for HIV-1, the virus that causes AIDS. A new detailed structural analysis of the complex formed by an anti-HIV antibody called 4E10 and its specific target provides insight into why this particular antibody is so broadly effective, a rare characteristic for HIV discovered thus far. The research is published in the Fe...Male circumcision reduces risk of HIV transmission from women to men
The first study to examine the probability ofHIV infection per act of heterosexual sex among a population withmultiple sexual partners has found that uncircumcised men have morethan twice the risk of acquiring HIV than do circumcised men.In the study, published in the Feb. 15 issue of The Journal ofInfectious Diseases, now available online, Jared Baeten and colleaguesfrom the United States...A much-needed shot in the arm for HIV vaccine development
International efforts towards developing avaccine against HIV infection have been given a much-needed boost bythe publication today of the Global HIV/AIDS Vaccine Enterprise'sscientific strategic plan, published online in the freely available,open-access global health journal PLoS Medicine.The Global HIV/AIDS Vaccine Enterprise is an international alliance ofindependent agencies and organiz...HIV-1 p24 ELISA Kit, Alliance (480 Tests) from PerkinElmer
Description:The PerkinElmer kit provides reagents for immune complex disruption (ICD) of antigen/antibody complexes in serum and plasma samples using a combination of low pH and heat. The samples are then neutralized and transferred to microplate wells which are coated with a highly specific mouse monoclonal antibody to HIV-1 p24. The immobilized monoclonal antibody captures both free HIV-1 p24 and that whic...HIV Volume 2 (Biochemistry, Molecular Biology and Drug Discovery) from Promega
Description:J. Karn (1995) This volume provides excellent background information, detailed practical information and methods for the study of major HIV proteins including: the HIV growth cycle; reverse transcriptase, ribonuclease H, integrase and protease. Expression of HIV proteins using baculoviruses; RNA binding assays; Tat and Rev assays; HIV/CD4 interactions; transient assays for Nef-induced down regu...Detecting Gastrin-Releasing Peptide Receptor by in situ PCR on Archived Tissue
In situ Adapter for the RoboCycler 40 Temperature Cycler allows rapidamplification of rare mRNA Department of Medicine, University of Illinois at Chicago Figure 1: RoboCycler 40 Temperature Cycler In Situ Adapter Syst...Recombinant HIV Reverse Transcriptase
Ideal for reverse transcribing transcripts with high G/C content...MailFoundry introduces new e-mail archive product
Businesses large and small now are using e-mail archives as tactical tools to address human resource issues, customer-relations management, and data recovery in the event of a lost laptop or a crashed hard drive. With their multi-faceted functionality...EraGen collaborates with Emory University on HIV detection system
MADISON - to develop a quantitative genotyping system useful in the early detection of the HIV variants. The partnership is supported by an NIH STTR g...Studies Offer New Insight into HIV Vaccine Development
MADISON-Mutations that allow AIDS viruses to escape detection by the immune system may also hinder the viruses' ability to grow after transmission to new hosts, scientists at the University of Wisconsin-Madison announced this week in the journal Nature Medicine. The discovery may help researchers design vaccines that exploit the notorious mutability of HIV by training the immune system t...Patients With Filariasis More Prone To HIV Infection
According to a report published in the December issue of the Journal of Infectious Diseases, HIV infection is significantly enhanced in peripheral blood mononuclear cells (PBMCs) from individuals with untreated filarial infection compared to PBMCs from infected patients treated with antifilarial agents. According to Dr. Ramya Gopinath and her team at the National Institute of Allergy and...International community warns India on HIV situation
The International Community has warned India that it is time to treat the HIV situation as a national emergency. Experts attending the Peoples Health Assembly at Dhaka, Bangladesh , have cautioned India not to be complacent about the looming HIV crisis in the country. Rebuffing the optimistic statement of Union Health Minister, Dr.C.P.Takhur, the experts said if corrective measures are no...Debate Rages over firing of HIV infected health care workers
When we flip through the news papers it isn’t uncommon for us to see news items which tell us that an employee has been fired from an establishment after testing positive for HIV. But rarely do these matters become a major controversy when many sit up and take notice. Especially in the health care industry people don’t bat an eyelid when someone is fired because of ones HIV serostatus. Ma...HIV infected patients can travel safely abroad
Many HIV infected patients, apart from suffering the social neglect and being unwanted even by near and dear ones have this major handicap - they just can’t travel like the other people - wherever they want and whenever they want. Some people just avoid having HIV infected co passengers. Others are just indifferent. Leaving the ethical issues aside, it is very difficult for these victims...Man against HIV – new vaccine ready for human trials
A new vaccine called the TAT vaccine has been developed in Italy as the latest and most exciting HIV vaccine to date. And more importantly it has had a 71% success rate when tested on monkeys. This vaccine is now ready for human testing and this may be the brightest hope for mankind against the destructive HIV. Dr.Barbara Ensoli, Head of the Department of Virology at Italy’s National Hea...Centricity Cardiology- Image Management and Archive
Description:GE's complex Cath Lab solution enhances your productivity and workflow efficiency across your department, your facility and your entire enterprise....Beehive Millennium - Long-term Epilepsy Monitoring
Description:Beehive Millennium, the newest entry in the Beehive product line, combines decades of experience in epilepsy monitoring with the technology of the 21st century. Beehive Millennium is a powerful Windows-based digital Video/EEG instrument, providing complete data acquisition, recording and review capabilities that are specialized for epilepsy monitoring applications. Beehive Millennium features ult...OraSure HIV-1 Oral Specimen Collection Device
Description:Testing with an OraSure HIV-1 Oral Specimen Collection Device is a safe, easy, and reliable way to test for HIV-1 antibodies. Testing with the OraSure HIV-1 Oral Specimen Collection Device requires no blood or needles and has been shown to be more than 99% accurate. OraSure HIV-1 uses a specially treated cotton fiber pad attached to a nylon stick which is placed between the lower cheek and gu...OraQuick ADVANCE Rapid HIV-1/2 Antibody Test
Description:The OraQuick ADVANCE Rapid HIV-1/2 Antibody Test is a single-use, qualitative immunoassay to detect antibodies to Human Immunodeficiency Virus Type 1 (HIV-1) and Type 2 (HIV-2) in oral fluid, fingerstick whole blood, venipuncture whole blood, and plasma specimens....Rapid HIV Testing Increases Possibility of Treatment
According to a November, 2005 joint press release from UNAIDS (Joint United Nations Programme on HIV/AIDS) and the World Health Organization, the number of people living with HIV globally reached an estimated high of 40.3 million people in 2005, with over 3 million deaths caused by AIDS. The latest data from...New Drugs in Multinational Study Show Promise in Fighting Drug-Resistant HIV
Phase III clinical trial provides hope that HIV patients can livelonger lives PASADENA, Calif., July 05, 2007 /PRNewswire/ -- A newinvestigational drug used in combination with a second newer agenthas proven to be effective in fighting drug-resistant HIV,according to a Lancet article to be published in its July 7thspecial HIV/AIDS issue. The multinational phase III clinical trial,...